http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200200294-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2000-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200200294-A1
titleOfInvention SPHERICAL AGLOMERATES OF THYLTROMYCINE, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION FOR PREPARATION OF MEDICINAL FORMS
abstract The object of the present invention are spherical agglomerates of telithromycin. The subject of the invention is a method characterized in that a suspension of telithromycin crystals is prepared and then the crystals are coated with a phase that is not soluble in telithromycin, which gradually crystallizes. The spherical agglomerates of telithromycin are used in the preparation of microcapsules. The international search report was published 2001.06.21.
priorityDate 1999-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3002190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410837595

Total number of triples: 21.